• Citer

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

par Diener, Hans-Christoph;Sacco, Ralph L.;Yusuf, Salim;Cotton, Daniel;Ounpuu, Stephanie;Lawton, William A;Palesch, Yuko;Martin, Ricardo;Albers, Gregory W;Bath, Philip;Bornstein, Natan;Chan, Bernard PL;Chen, Sien-Tsong;Cunha, Luis;Dahlöf, Björn;De Keyser, Jacques;Donnan, Geoffrey A;Estol, Conrado;Gorelick, Philip;Gu, Vivian;Hermansson, Karin;Hilbrich, Lutz;Kaste, Markku;Lu, Chuanzhen;Machnig, Thomas;Pais, Prem;Roberts, Robin;Skvortsova, Veronika;Teal, Philip;Toni, Danilo;VanderMaelen, Cam;Voigt, Thor;Weber, Michaël;Yoon, Byung-Woo;Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group, Massimo;Pandolfo,
Référence Lancet neurology, 7, 10, page (875-884)
Publication Publié, 2008-10

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
Auteur:	Diener, Hans-Christoph; Sacco, Ralph L.; Yusuf, Salim; Cotton, Daniel; Ounpuu, Stephanie; Lawton, William A; Palesch, Yuko; Martin, Ricardo; Albers, Gregory W; Bath, Philip; Bornstein, Natan; Chan, Bernard PL; Chen, Sien-Tsong; Cunha, Luis; Dahlöf, Björn; De Keyser, Jacques; Donnan, Geoffrey A; Estol, Conrado; Gorelick, Philip; Gu, Vivian; Hermansson, Karin; Hilbrich, Lutz; Kaste, Markku; Lu, Chuanzhen; Machnig, Thomas; Pais, Prem; Roberts, Robin; Skvortsova, Veronika; Teal, Philip; Toni, Danilo; VanderMaelen, Cam; Voigt, Thor; Weber, Michaël; Yoon, Byung-Woo; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group, Massimo; Pandolfo,
Informations sur la publication:	Lancet neurology, 7, 10, page (875-884)
Statut de publication:	Publié, 2008-10
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Aged
	Angiotensin II Type 1 Receptor Blockers -- therapeutic use
	Aspirin -- therapeutic use
	Benzimidazoles -- therapeutic use
	Benzoates -- therapeutic use
	Cognition -- drug effects
	Dipyridamole -- therapeutic use
	Disability Evaluation
	Double-Blind Method
	Drug Administration Schedule
	Drug Delivery Systems
	Drug Therapy, Combination
	Female
	Follow-Up Studies
	Humans
	International Cooperation
	Male
	Mental Status Schedule
	Middle Aged
	Platelet Aggregation Inhibitors -- therapeutic use
	Recurrence -- prevention & control
	Retrospective Studies
	Severity of Illness Index
	Stroke -- physiopathology
	Stroke -- prevention & control
	Ticlopidine -- analogs & derivatives
	Ticlopidine -- therapeutic use
Note générale:	Clinical Trial
	Comparative Study
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
	Erratum in : Lancet Neurology, 2008; 7; 985
Langue:	Anglais
Identificateurs:	urn:issn:1474-4422
	info:doi/10.1016/S1474-4422(08)70198-4
	info:pii/S1474-4422(08)70198-4
	info:pmid/18757238
	PMC2772657